Full-Time

Category Buyer Raw Materials

Bioprocess Materials, Consumable, Sut, Chromatog, Resin, Media

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Mid

Framingham, MA, USA + 1 more

More locations: East Side, PA, USA

Category
Procurement & Sourcing
Operations & Logistics
Requirements
  • 5 years' experience in Procurement/Buying within Pharmaceuticals, Aerospace, Automotive or FMCG.
  • Bachelor’s degree from accredited University.
  • Supplier landscape know-how & demonstrated track record of achieving significant cost savings.
  • Strong understanding of raw materials’ procurement value chain from R&D up to LCM, their supply chain dynamics and industry trends.
  • Good knowledge of bioprocess suppliers' landscapes along with their respective capabilities.
  • Strong negotiation and contract management skills with the ability to lead complex supplier relationships.
  • Excellent command of English is a must. French is a plus.
Responsibilities
  • Develop innovative sub-category strategies that have measurable benefit for Sanofi.
  • Negotiate worldwide and deliver savings based on anticipation and consolidation of all business needs.
  • Drive major transversal category initiatives to build up state of the art practices and innovation in sourcing.
  • Leverage both generative and predictive Artificial Intelligence in sourcing, scenario, and result augmentation.
  • Ensure procurement technical excellence such as TCO, SRM, Market Intelligence, Risk Management, Innovation, Digital, CSR, HSE, compliance, quality at Global Level.
  • Manage Global Business Reviews with strategic partners to ensure ambition and execution in both sides.
  • Directly impact a €10 billion company revenue and support over 6 product launches in new vaccines over the next 5 years.
  • Oversee key account management for strategic suppliers managing relationships.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?